Vincent A
Neurosciences Group, Department of Clinical Neurology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Acta Neurol Scand Suppl. 2006;183:1-7. doi: 10.1111/j.1600-0404.2006.00605.x.
The neuromuscular junction (NMJ) is a prototype synapse and myasthenia gravis is the prototypic antibody-mediated disorder. There are now three other disorders of neuromuscular transmission caused by antibodies to other essential components of the NMJ. Antibodies to the muscle-specific kinase, MuSK, are defining a new form of myasthenia that can be associated with muscle atrophy. Antibodies to voltage-gated calcium channels are responsible for muscle weakness and autonomic dysfunction in the Lambert Eaton myasthenic syndrome. Antibodies to voltage-gated potassium channels are found in patients with a range of disorders affecting the NMJ, the autonomic system or the central nervous system. The pathogenic mechanisms probably depend on the IgG subclass of the antibodies and are only partly shared between the diseases.
神经肌肉接头(NMJ)是一种典型的突触,重症肌无力是典型的抗体介导性疾病。目前,还有另外三种由针对NMJ其他重要成分的抗体引起的神经肌肉传递障碍。针对肌肉特异性激酶MuSK的抗体正在定义一种新的重症肌无力形式,这种形式可能与肌肉萎缩有关。针对电压门控钙通道的抗体是兰伯特-伊顿肌无力综合征中肌肉无力和自主神经功能障碍的病因。在一系列影响NMJ、自主神经系统或中枢神经系统的疾病患者中发现了针对电压门控钾通道的抗体。致病机制可能取决于抗体的IgG亚类,并且在这些疾病之间仅部分相同。